Pentagon rescinds new testosterone screening policy without explanation

The US Department of Defense has abruptly withdrawn a newly released clinical guidance document that mandated testosterone screening for military personnel. The policy, initially announced by Defense Secretary Pete Hegseth in July, was formalized in a document released on September 2, only to be removed from public view the following day. Alongside the document, a statement from spokesperson Sean Parnell was also retracted. The Pentagon confirmed to Ars Technica that the guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was temporarily rescinded on September 3 to facilitate updates. The sudden reversal, first reported by Reuters, has left observers seeking clarity on the future of the controversial medical mandate. While the military claims the move is for administrative updates, the lack of a detailed explanation has fueled speculation regarding the policy's medical validity and its potential long-term implementation within the armed forces.